Skip to main content
Home Startups DMC Biotechnologies

DMC Biotechnologies

Engineered microbial hosts using synthetic metabolic valves

DMC is leading the low cost, sustainable transformation of multiple product markets.  Their novel, patent-pending technology for rapid engineering of robust microbial hosts enables the production of a broad diversity of specialty chemicals, flavors, fragrances, nutraceuticals, natural products, and pharmaceuticals.

Deployment of their Synthetic Metabolic Valve technology dramatically reduces the cost and development timeline from discovery to commercial performance.  Their ultra low cost development will democratize metabolic engineering efforts, creating a multitude of commercially viable bioprocesses and delivering sustainable routes to both new and existing products.

Bill Gates-led $1 billion Energy Fund is Expanding its Portfolio of Startups Fighting Climate Change